All very true. One of the frustrating - but completely understandable - things about this pandemic has been the lack of (or sometimes moving) data/information about risk. It's not that "they" won't tell us, of course. It's because the studies take time to do, the methodologies need to be scrutinized, and the variants that have sprung up keep changing things more rapidly than the data flow can keep up. Unfortunately, there is no clear answer to what is a vaxxed person's risk of contracting COVID while in a place like Bonaire when all contact with strangers is either outdoors or while masked indoors. All we know is that it is pretty low, but not zero.This is what I was getting at in a previous post. For many years I have self-insured--that is, borne all the financial risk--for most travel risks, including so-called Trip Interruption--because I felt I had an rough intuitive grasp of how "low" the probability of me getting stuck somewhere was and the costs I might have to bear. But for Covid, especially the more transmissible (how much more?!) variant(s), I just don't feel I have a reasonable grasp of the risk. Before the rise of Delta, experts told us (at least as I recall it) that the likelihood of transmission while walking past people on a sidewalk was so low that we didn't need to be concerned about it. Same for open-air dining with well-spaced tables. Now, they are saying Delta is much more transmissible, but I haven't heard any similar real-world examples, such as walking past people on a sidewalk or dining outside. So I don't know how to judge the new probabilities. As for the costs, an unexpected night in a hotel and dinner is one thing, but 10 days at whatever resort on Bonaire might be willing to put up quarantiners is another. Pre-covid, paying $100 for mainly a Trip Interruption benefit didn't seem worthwhile to me. Now?
I'm fairly confident that being vaxed, I wouldn't have any serious symptoms if I were to test positive. But, as I understand it, even vaxed people can contract enough virus to test positive.